Drugs Made in America Acquisition Corp.’s (NASDAQ:DMAAU) Quiet Period To End on March 10th

Drugs Made in America Acquisition’s (NASDAQ:DMAAU – Get Free Report) quiet period is set to expire on Monday, March 10th. Drugs Made in America Acquisition had issued 20,000,000 shares in its IPO on January 28th. The total size of the offering was $200,000,000 based on an initial share price of $10.00. During Drugs Made in America Acquisition’s quiet period, insiders and any underwriters involved in the IPO are prevented from issuing any research reports for the company because of SEC regulations. Following the end of the company’s quiet period, the brokerages that served as underwriters will likely initiate research coverage on the company.

Drugs Made in America Acquisition Trading Up 0.9 %

Drugs Made in America Acquisition stock opened at $10.20 on Monday. Drugs Made in America Acquisition has a one year low of $10.00 and a one year high of $10.82.

Drugs Made in America Acquisition Company Profile

(Get Free Report)

Want More Great Investing Ideas?

Drugs Made In America Acquisition Corp. is a blank check company newly incorporated in the Cayman Islands as an exempted company incorporated for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or other similar business combination with one or more businesses.
See Also

Receive News & Ratings for Drugs Made in America Acquisition Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Drugs Made in America Acquisition and related companies with MarketBeat.com’s FREE daily email newsletter.

Source link : http://www.bing.com/news/apiclick.aspx?ref=FexRss&aid=&tid=67c566f925764dd498a66b0bbd144aaa&url=https%3A%2F%2Fwww.etfdailynews.com%2F2025%2F03%2F03%2Fdrugs-made-in-america-acquisition-corp-s-nasdaqdmaau-quiet-period-to-end-on-march-10th%2F&c=8845608618247143571&mkt=en-us

Author :

Publish date : 2025-03-02 16:22:00

Copyright for syndicated content belongs to the linked Source.